Skye Bioscience, Inc. Common Stock Financial Flexibility Index
Skye Bioscience, Inc. Common Stock financial flexibility index. Skye Bioscience, Inc. Common Stock (SKYE) has a Financial Flexibility Index of -0.62x as of June 2026. Free cash flow of $-7.12 Million (operating CF $-7.12 Million minus capex $0.00) represents -1% of total liabilities ($11.53 Million). See SKYE FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Skye Bioscience, Inc. Common Stock (2012–2025)
Financial flexibility index of Skye Bioscience, Inc. Common Stock from 2012 to 2025. Historical Financial Flexibility Index trend for Skye Bioscience, Inc. Common Stock across 14 annual periods. Check earnings quality score of Skye Bioscience, Inc. Common Stock to evaluate the quality of earnings relative to operating cash generation.
Skye Bioscience, Inc. Common Stock Financial Flexibility Index by Year (2012–2025)
Skye Bioscience, Inc. Common Stock financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Skye Bioscience, Inc. Common Stock. For the full cash flow conversion analysis, see Skye Bioscience, Inc. Common Stock (SKYE) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.19x | $-43.06 Million | $-43.06 Million | $8.29 Million | ▼ -1.4% |
| 2024 | -5.12x | $-23.63 Million | $-25.24 Million | $4.61 Million | ▼ -417.3% |
| 2023 | -0.99x | $-13.94 Million | $-13.95 Million | $14.07 Million | ▲ +5.6% |
| 2022 | -1.05x | $-12.72 Million | $-12.74 Million | $12.12 Million | ▲ +34.4% |
| 2021 | -1.60x | $-6.38 Million | $-6.47 Million | $3.99 Million | ▲ +41.2% |
| 2020 | -2.72x | $-6.05 Million | $-6.05 Million | $2.22 Million | ▲ +34.5% |
| 2019 | -4.16x | $-6.02 Million | $-6.03 Million | $1.45 Million | ▼ -1748.6% |
| 2018 | -0.22x | $-3.94 Million | $-3.94 Million | $17.52 Million | ▲ +90.7% |
| 2017 | -2.42x | $-3.28 Million | $-3.30 Million | $1.36 Million | ▼ -21.0% |
| 2016 | -2.00x | $-3.54 Million | $-3.55 Million | $1.77 Million | ▼ -62.9% |
| 2015 | -1.23x | $-3.73 Million | $-3.73 Million | $3.04 Million | ▲ +43.3% |
| 2014 | -2.16x | $-1.73 Million | $-1.76 Million | $801.89K | ▼ -1236.4% |
| 2013 | 0.19x | $34.62K | $-14.49K | $182.15K | ▼ -57.4% |
| 2012 | 0.45x | $1.93K | $1.93K | $4.33K | — |